• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

JAK2抑制剂AZD1480可抑制甲型肝炎病毒在Huh7细胞中的复制。

The JAK2 inhibitor AZD1480 inhibits hepatitis A virus replication in Huh7 cells.

作者信息

Jiang Xia, Kanda Tatsuo, Nakamoto Shingo, Saito Kengo, Nakamura Masato, Wu Shuang, Haga Yuki, Sasaki Reina, Sakamoto Naoya, Shirasawa Hiroshi, Okamoto Hiroaki, Yokosuka Osamu

机构信息

Department of Gastroenterology and Nephrology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan.

Department of Gastroenterology and Nephrology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan.

出版信息

Biochem Biophys Res Commun. 2015 Mar 20;458(4):908-12. doi: 10.1016/j.bbrc.2015.02.058. Epub 2015 Feb 19.

DOI:10.1016/j.bbrc.2015.02.058
PMID:25704089
Abstract

The JAK2 inhibitor AZD1480 has been reported to inhibit La protein expression. We previously demonstrated that the inhibition of La expression could inhibit hepatitis A virus (HAV) internal ribosomal entry-site (IRES)-mediated translation and HAV replication in vitro. In this study, we analyzed the effects of AZD1480 on HAV IRES-mediated translation and replication. HAV IRES-mediated translation in COS7-HAV-IRES cells was inhibited by 0.1-1 μM AZD1480, a dosage that did not affect cell viability. Results showed a significant reduction in intracellular HAV HA11-1299 genotype IIIA RNA levels in Huh7 cells treated with AZD1480. Furthermore, AZD1480 inhibited the expression of phosphorylated-(Tyr-705)-signal transducer and activator of transcription 3 (STAT3) and La in Huh7 cells. Therefore, we propose that AZD1480 can inhibit HAV IRES activity and HAV replication through the inhibition of the La protein.

摘要

据报道,JAK2抑制剂AZD1480可抑制La蛋白表达。我们之前证明,抑制La表达可在体外抑制甲型肝炎病毒(HAV)内部核糖体进入位点(IRES)介导的翻译及HAV复制。在本研究中,我们分析了AZD1480对HAV IRES介导的翻译和复制的影响。在COS7-HAV-IRES细胞中,0.1-1μM的AZD1480可抑制HAV IRES介导的翻译,该剂量不影响细胞活力。结果显示,用AZD1480处理的Huh7细胞中,细胞内HAV HA11-1299 IIIA型基因型RNA水平显著降低。此外,AZD1480可抑制Huh7细胞中磷酸化-(酪氨酸-705)-信号转导和转录激活因子3(STAT3)及La的表达。因此,我们认为AZD1480可通过抑制La蛋白来抑制HAV IRES活性及HAV复制。

相似文献

1
The JAK2 inhibitor AZD1480 inhibits hepatitis A virus replication in Huh7 cells.JAK2抑制剂AZD1480可抑制甲型肝炎病毒在Huh7细胞中的复制。
Biochem Biophys Res Commun. 2015 Mar 20;458(4):908-12. doi: 10.1016/j.bbrc.2015.02.058. Epub 2015 Feb 19.
2
The sirtuin inhibitor sirtinol inhibits hepatitis A virus (HAV) replication by inhibiting HAV internal ribosomal entry site activity.沉默调节蛋白抑制剂西托辛通过抑制甲型肝炎病毒(HAV)内部核糖体进入位点活性来抑制HAV复制。
Biochem Biophys Res Commun. 2015 Oct 23;466(3):567-71. doi: 10.1016/j.bbrc.2015.09.083. Epub 2015 Sep 24.
3
Drug Screening for Hepatitis A Virus (HAV): Nicotinamide Inhibits c-Jun Expression and HAV Replication.肝炎病毒 A(HAV)的药物筛选:烟酰胺抑制 c-Jun 表达和 HAV 复制。
J Virol. 2023 Feb 28;97(2):e0198722. doi: 10.1128/jvi.01987-22. Epub 2023 Feb 2.
4
Rapid and convenient assays to assess potential inhibitory activity on in vitro hepatitis A replication.快速便捷的检测方法,用于评估体外甲型肝炎复制的潜在抑制活性。
Antiviral Res. 2013 May;98(2):325-31. doi: 10.1016/j.antiviral.2013.03.016. Epub 2013 Mar 23.
5
Suppression of hepatitis A virus genome translation and replication by siRNAs targeting the internal ribosomal entry site.靶向内部核糖体进入位点的小干扰RNA对甲型肝炎病毒基因组翻译和复制的抑制作用
Biochem Biophys Res Commun. 2005 May 20;330(4):1217-23. doi: 10.1016/j.bbrc.2005.03.105.
6
Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha.金刚烷胺与干扰素-α联合抑制 HAV IRES 介导的翻译和复制。
Virol J. 2010 Sep 3;7:212. doi: 10.1186/1743-422X-7-212.
7
Interleukin-29 suppresses hepatitis A and C viral internal ribosomal entry site-mediated translation.白细胞介素-29 抑制甲型肝炎和丙型肝炎病毒内部核糖体进入位点介导的翻译。
Viral Immunol. 2012 Oct;25(5):379-86. doi: 10.1089/vim.2012.0021.
8
Suppression of La antigen exerts potential antiviral effects against hepatitis A virus.抑制La抗原对甲型肝炎病毒具有潜在的抗病毒作用。
PLoS One. 2014 Jul 7;9(7):e101993. doi: 10.1371/journal.pone.0101993. eCollection 2014.
9
Amantadine and Rimantadine Inhibit Hepatitis A Virus Replication through the Induction of Autophagy.金刚烷胺和金刚乙胺通过诱导自噬抑制甲型肝炎病毒复制。
J Virol. 2022 Sep 28;96(18):e0064622. doi: 10.1128/jvi.00646-22. Epub 2022 Aug 30.
10
AZD1480, a JAK inhibitor, inhibits cell growth and survival of colorectal cancer via modulating the JAK2/STAT3 signaling pathway.AZD1480,一种JAK抑制剂,通过调节JAK2/STAT3信号通路抑制结直肠癌的细胞生长和存活。
Oncol Rep. 2014 Nov;32(5):1991-8. doi: 10.3892/or.2014.3477. Epub 2014 Sep 10.

引用本文的文献

1
Identification of Mulberrofuran as a potent inhibitor of hepatitis A virus 3C and RdRP enzymes through structure-based virtual screening, dynamics simulation, and DFT studies.通过基于结构的虚拟筛选、动力学模拟和 DFT 研究鉴定 Mulberrofuran 为一种有效的甲型肝炎病毒 3C 和 RdRP 酶抑制剂。
Mol Divers. 2024 Jun;28(3):1609-1628. doi: 10.1007/s11030-023-10679-7. Epub 2023 Jun 29.
2
The antiviral potential of Phyllanthus species: a systematic review.叶下珠属植物的抗病毒潜力:系统评价。
Arch Virol. 2023 Jun 13;168(7):177. doi: 10.1007/s00705-023-05802-w.
3
Masitinib Inhibits Hepatitis A Virus Replication.
马替尼抑制甲型肝炎病毒复制。
Int J Mol Sci. 2023 Jun 3;24(11):9708. doi: 10.3390/ijms24119708.
4
Treatment Options for Hepatitis A and E: A Non-Systematic Review.甲型和戊型肝炎的治疗选择:非系统性综述。
Viruses. 2023 Apr 28;15(5):1080. doi: 10.3390/v15051080.
5
Drug Screening for Hepatitis A Virus (HAV): Nicotinamide Inhibits c-Jun Expression and HAV Replication.肝炎病毒 A(HAV)的药物筛选:烟酰胺抑制 c-Jun 表达和 HAV 复制。
J Virol. 2023 Feb 28;97(2):e0198722. doi: 10.1128/jvi.01987-22. Epub 2023 Feb 2.
6
Hepatitis A: Viral Structure, Classification, Life Cycle, Clinical Symptoms, Diagnosis Error, and Vaccination.甲型肝炎:病毒结构、分类、生命周期、临床症状、诊断失误及疫苗接种
Can J Infect Dis Med Microbiol. 2023 Jan 4;2023:4263309. doi: 10.1155/2023/4263309. eCollection 2023.
7
Influence of seasonal and geographic variation on the anti-HSV-1 properties and chlorogenic acids content of Sch. Bip.季节和地理变化对双花千里光抗单纯疱疹病毒1型特性及绿原酸含量的影响
Front Mol Biosci. 2022 Aug 25;9:961859. doi: 10.3389/fmolb.2022.961859. eCollection 2022.
8
Therapeutic Advances in Viral Hepatitis A-E.《病毒性肝炎治疗进展》A-E 分册。
Adv Ther. 2022 Apr;39(4):1524-1552. doi: 10.1007/s12325-022-02070-z. Epub 2022 Feb 27.
9
Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment.甲型肝炎:流行病学、高危人群、预防和抗病毒治疗研究。
Viruses. 2021 Sep 22;13(10):1900. doi: 10.3390/v13101900.
10
The global trends and regional differences in incidence and mortality of hepatitis A from 1990 to 2019 and implications for its prevention.1990 年至 2019 年全球甲型肝炎发病率和死亡率的趋势和地区差异及其预防意义。
Hepatol Int. 2021 Oct;15(5):1068-1082. doi: 10.1007/s12072-021-10232-4. Epub 2021 Aug 3.